However, recent research has shown that RSK4 is expressed at low levels in malignant ovarian tumors which correlate with advanced stages of the disease, and cisplatin increases the expression of RSK4 in SKOV3 and TOV112D ovarian cancer cell lines [94]. This evidence concerns the gene RPS6KA6 and ovarian cancer.